K. Nolan

发表

Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis

G. Mccarthy, A. Peace, D. Kenny, 2016, Clinical Rheumatology.

The productive conformation of prostaglandin G2 at the peroxidase site of prostaglandin endoperoxide H synthase: docking, molecular dynamics, and site-directed mutagenesis studies.

D. Fitzgerald, A. Chubb, K. Nolan, 2006, Biochemistry.

Reactions of co-ordinated imines. Part I. Kinetics and mechanism of hydrolysis of N-2-pyridylmethyleneaniline both in the presence and absence of copper(II) ions

K. Nolan, R. Hay, 1976 .

Genomes2Drugs: Identifies Target Proteins and Lead Drugs from Proteome Data

Heinrich C. Hoppe, David Toomey, Anthony J. Chubb, 2009, PloS one.

Ruthenium(III) readily abstracts NO from L-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthases.

T. Murphy, K. Nolan, C. Marmion, 2001, Chemical communications.

A novel family of hydroxamate-based acylating inhibitors of cyclooxygenase.

D. Fitzgerald, M. Devocelle, K. Nolan, 2003, Molecular pharmacology.

Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity.

Mauro F. A. Adamo, A. Chubb, Ahmed Alagha, 2009, Bioorganic & medicinal chemistry letters.

The preparation and crystal structure of acetatobis(l-arginine)zinc(II) acetate trihydrate, the first reported X-ray structure of a zinc(II)–arginine complex

H. Müller‐Bunz, David A. Brown, Ahmed Alagha, 2011 .

Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands

K. Nolan, D. Griffith, C. Marmion, 2004 .

Speciation, stability constants and structures of complexes of copper(II), nickel(II), silver(I) and mercury(II) with PAMAM dendrimer and related tetraamide ligands

K. Nolan, A. D. Namor, Krystyna A. Krot, 2005 .

Metal complexes of sterically hindered porphyrins. Crystal and molecular structure of meso-tetrakis(3,5-di-t-butyl-4-hydroxyphenyl)porphyrin-nickel(II)

K. Nolan, T. Traylor, D. Povey, 1988 .

Effects of phytate on mineral bioavailability. in vitro studies on Mg2+, Ca2+, Fe3+, Cu2+ and Zn2+ (also Cd2+) solubilities in the presence of phytate

D. McWeeny, K. Nolan, P. Duffin, 1987 .

In vitro hydrolysis of phytate at 95°C and the influence of metal ion on the rate

K. Nolan, J. I. Bullock, P. Duffin, 1993 .

The structure of the palladium(II) and zinc(II) complexes of α,β,γ,δ-tetrakis(3,5-di-tert-butyl-4-hydroxyphenyl)porphyrin

L. Milgrom, K. Nolan, D. Povey, 1988 .

Metal complexes of ethylenediaminetetraacetamide

K. Nolan, R. Hay, Mohammed Shuaib, 1979 .

Reactions of co-ordinated nitriles. Part I. Reactions of cis-(aminoacetonitrile)bis(ethylenediamine)halogenocobalt(III) complexes in aqueous solution

K. Nolan, R. Hay, 1974 .

Synthesis and characterisation of mercaptoimidazole, mercaptopyrimidine and mercaptopyridine complexes of platinum(II) and platinum(III). The crystal and molecular structures of tetra(2-mercaptobenzimidazole)- and tetra(2-mercaptoimidazole)platinum(II) chloride

K. Nolan, R. Pritchard, W. I. Cross, 2001 .

Metal complexes of salicylhydroxamic acid (H2Sha), anthranilic hydroxamic acid and benzohydroxamic acid. Crystal and molecular structure of [Cu(phen)2(Cl)]Cl x H2Sha, a model for a peroxidase-inhibitor complex.

D. Fitzgerald, M. Gil, K. Nolan, 2000, Journal of inorganic biochemistry.

Polyvalent porphyrins. 1. Properties of tetrakis(3,5-di-tert-butyl-4-hydroxyphenyl)porphyrin (1-P) and its iron(III) and zinc(II) derivatives

K. Nolan, T. Traylor, R. Hildreth, 1983 .

Complex formation between transition metal ions and salicylglycine, a metabolite of aspirin

N. Daéid, K. Nolan, E. Farkas, 1994 .

Metal complexes of cyclic hydroxamates. Synthesis and crystal structures of 3-hydroxy-2-methyl-3H-quinazolin-4-one (ChaH) and of its Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes

H. Müller‐Bunz, L. Parthasarathi, Ahmed Alagha, 2011 .

Reactions of 1,2-diaminoethane-N,N,N′N′-tetra(N-methylacetamide), L, with potassium tetrachloroplatinate(II). Crystal and molecular structures of Pt(LH−2)Cl2·2H2O, a novel platinum(IV) complex containing deprotonated amide ligands, and of (2H+-L) [PtCl4]

K. Nolan, A. Castiñeiras, Colm J. Campbell, 1996 .

5-Chloro-3-hydroxy-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-one: supramolecular aggregation through a two-dimensional network of N—H⋯O and O—H⋯O interactions

M. Devocelle, E. C. Spencer, K. Nolan, 2006 .

Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium(III) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigations.

K. Nolan, D. Griffith, C. Marmion, 2008, Dalton transactions.

Synthesis, structures and speciation studies of ruthenium(III) hydroxamate/hydroximato complexes. Crystal and molecular structure of hydrated [Ru(H2edta)(2-methoxyphenylhydroxamate)], the first structurally characterised ruthenium(III)-hydroxamate complex

K. Nolan, R. Pritchard, E. Farkas, 2003 .

Metal complexes of taurine. The first reported solution equilibrium studies for complex formation by taurine at physiological pH; the copper(II)-glycylglycinate-taurine and the copper(II)-glycylaspartate-taurine systems.

A. Rockenbauer, K. Nolan, E. Farkas, 1999, Journal of inorganic biochemistry.

Synthesis and characterisation of copper(II), zinc(II) and cobalt(II) complexes of salicylglycine, a metabolite of aspirin

K. Nolan, A. Soudi, Ali A. Soudi, 1995 .

The First Crystal Structures of Mercury(II) Complexes of Tetra‐amides (L1 and L2) and Tetramethylamides (L3 and L4) of EDTA and PDTA. Formation of Distorted Octahedral and Distorted Capped Octahedral Mercury(II) Complexes and of a Trinuclear Complex containing HgCl2‐bridged [Hg(L3)Cl]+ Moieties

A. Llamas-Saiz, K. Nolan, N. Vembu, 2007 .

Copper(II) complexes of aminolysis products of the anticancer bis(3,5-dioxopiperazin-l-yl)alkanes in aqueous solution

K. Nolan, L. P. Ryan, 1993 .

Metal complexes of tetramethylethylenediaminetetraacetate

K. Nolan, R. Hay, Mohammed Shuaib, 1980 .

Reactions of co-ordinated ligands. Hydrolysis of tetramethyl ethylenediaminetetra-acetate and its copper(II) complexes

K. Nolan, R. Hay, 1975 .

Synthesis and structure of a heptanuclear nickel(II) complex uniquely exhibiting four distinct binding modes, two of which are novel, for a hydroxamate ligand.

W. Haase, K. Nolan, Z. Starikova, 2002, Chemical communications.

Copper(II) complexes of isomeric aminophenylhydroxamic acids. A novel 'clam-like' dimeric metallacrown and polymeric helical structure containing interlinked unique copper(II) sites

W. Haase, K. Nolan, Z. Starikova, 2001 .

Synthesis and antitumour activity of platinum(II) and platinum(IV) complexes containing ethylenediamine-derived ligands having alcohol, carboxylic acid and acetate substituents. Crystal and molecular structure of [PtL4CL2].H20 where L4 is ethylenediamine-N,N'-diacetate.

L. Kèlland, K. Nolan, J. N. Jolley, 2001, Journal of inorganic biochemistry.

Hydroxamic Acids: An Important Class of Metalloenzyme Inhibitors

K. Nolan, C. Marmion, J. P. Parker, 2013 .

Intramolecular imine formation. Synthesis and crystal structure of chloro(1,2-diaminoethane)[2-(2′-aminoethylimino)ethylamine]cobalt(III) chloride perchlorate monohydrate

K. Nolan, D. Povey, P. Ford, 1982 .

Base hydrolysis and mercury(II)-catalysed aquation of bis(ethylenediamine-NN′)(ethylenediamine-N)halogenocobalt(III) complexes

K. Nolan, R. Hay, 1975 .

Calixarenes: designer ligands for chemical sensors.

D. Diamond, K. Nolan, 2001, Analytical chemistry.

The first reported structure of a platinum(IV) complex containing deprotonated amide ligands—a model for platinum(IV)-peptide/protein interactions

K. Nolan, A. Castiñeiras, Colm J. Campbell, 1995 .

5,10,15,20-Mesotetrakis(3,5-di-t-butyl-4-quinomethide)porphyrinogen: a highly puckered tetrapyrrolic macrocycle from the facile aerial oxidation of a phenolic porphyrin

L. Milgrom, K. Nolan, D. Povey, 1989 .

A calix(4)arene pyridine derivative and its monomeric component: structural and thermodynamic aspects of their complexation with metal cations.

M. Shehab, N. Ouazzani, L. Mandi, 2005, The journal of physical chemistry. B.

An Experiment on Isomerism in Metal-Amino Acid Complexes.

K. Nolan, R. Harrison, 1982 .

Parallel synthesis and in vitro activity of novel anthranilic hydroxamate-based inhibitors of the prostaglandin H2 synthase peroxidase activity.

D. Fitzgerald, M. Devocelle, A. Chubb, 2005, Organic & biomolecular chemistry.

Base hydrolysis of cis-chloro(1-methylimidazole)bis(1,2-diaminoethane)cobalt(III) and related complex cations

K. Nolan, Maria C. Gomez-Vaamonde, 1985 .

Synthesis of trans-bis (glycinehydroxamato) platinum (II) hydrate tans-dichlorobis (glycylglycine) platinum (II) dihydrate and the crystal and molecular structures of trans-dichlorobis (glycine) platinum (II) dihydrate and trans, trans-dichlorobis (glycinato) platinum (IV), hydrolysis products forme

David A. Brown, K. Nolan, Hywel Davies, 1995 .

Metal complexes of salicylhydroxamic acid and O-acetylsalicylhydroxamic acid

D. Fitzgerald, K. Nolan, E. O’Brien, 1997 .

Metal complexes of amino acids and peptides

J. Jones, K. Nolan, R. Hay, 2002 .

Hydroxamic acids are nitric oxide donors. Facile formation of ruthenium(II)-nitrosyls and NO-mediated activation of guanylate cyclase by hydroxamic acids

T. Murphy, K. Nolan, C. Marmion, 2000 .

O-acetylsalicylhydroxamic acid, a novel acetylating inhibitor of prostaglandin H2 synthase: structural and functional characterization of enzyme-inhibitor interactions.

P. Loll, D. Fitzgerald, M. Devocelle, 2001, Molecular pharmacology.

The preparation and crystal and molecular structure of the complex cis-PtCl2(razoxane)

Kevin B. Nolan, Hywel O. Davies, K. Nolan, 1998 .

Preparation and Crystal Structure of a Platinum(II) Complex of [CH2N(CH2COOH)CH2CONH2]2, the Hydrolysis Product of an Anti-Tumour Bis(3,5-Dioxopiperazin-1-YL)Alkane

D. Cunningham, P. McArdle, K. Nolan, 1994, Metal-based drugs.

Observation of an unusual electronically distorted semiquinone radical of PCB metabolites in the active site of prostaglandin H synthase-2.

L. Robertson, G. Buettner, K. Nolan, 2010, Chemosphere.

A convenient parallel synthesis of low molecular weight hydroxamic acids using polymer-supported 1-hydroxybenzotriazole.

D. Fitzgerald, M. Devocelle, K. Nolan, 2003, Organic & biomolecular chemistry.

Bis(4-(2-pyridylmethylamino)phenyl)methane dihydrate

A. Llamas-Saiz, K. Nolan, N. Vembu, 2007 .

2-Amino-3,5-dichlorobenzohydroxamic acid: supramolecular aggregation through two-dimensional networks of O—H⋯N/O and N—H⋯O/Cl interactions

M. Devocelle, K. Nolan, N. Vembu, 2006 .

2-Methoxybenzohydroxamic acid: supramolecular aggregation through two-dimensional networks of N—H⋯O and O—H⋯O interactions

M. Devocelle, A. Linden, K. Nolan, 2006 .

2‐Amino‐5‐iodobenzohydroxamic acid: supramolecular aggregation through two‐dimensional networks of N—H⋯O, O—H⋯N and C—H⋯O interactions

M. Devocelle, A. Linden, K. Nolan, 2006 .

Effect of phytate on the in-vitro solubility of Al+, Ca2+, Hg2+ and Pb2+ as a function of pH at 37°C

K. Nolan, J. I. Bullock, P. Duffin, 1995 .

TIN - A Combinatorial Compound Collection of Synthetically Feasible Multicomponent Synthesis Products

Tim Heinemann, Dermot Cox, David Toomey, 2011, J. Chem. Inf. Model..

Hydroxamic Acids — An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands

K. Nolan, D. Griffith, C. Marmion, 2004 .

Oxidised metallophenolicporphyrins as models for compound I of the peroxidases. Reduction of oxidised iron(III), nickel(II) and zinc(II) complexes of meso-tetrakis(3,5-di-t-butyl-4-hydroxyphenyl)prophyrin by the peroxidase substrate p-cresol

N. Daéid, K. Nolan, 1993 .

Importance of macrocyclic ring deformation in the facile aerial oxidation of phenolic porphyrins

L. Milgrom, K. Nolan, D. Povey, 1987 .

fac-Tris(4-aminobenzohydroxamato)iron(III) ethanol solvate

H. Müller‐Bunz, L. Parthasarathi, Ahmed Alagha, 2010, Acta Crystallographica Section E.

Redetermination of fac-tris(benzohydroxamato)iron(III) trihydrate

T. Murphy, K. Nolan, Z. Starikova, 2000 .

Synthesis and hydrolysis of an ester of the ‘one ring open’ hydrolysis product of the anticancer drug 1,2-bis(3,5-dioxopiperazin-l-yl)propane, ‘Razoxane’

K. Nolan, E. Gonzalez, L. P. Ryan, 1994 .

Interaction of taurine with metal ions.

K. Nolan, E. Farkas, E. O’Brien, 2000, Advances in experimental medicine and biology.

KINETICS OF BASE HYDROLYSIS OF THE THREE (COCL(EN)(DIEN))2+ ISOMERS

K. Nolan, R. Hay, 1976 .

Reactions of coordinated nitriles, nucleophilic attack by amines on cis-dichlorobisbenzonitrileplatinum(II)

K. Nolan, C. A. Amodio, 1986 .

Synthetic porphyrins/metalloporphyrins which mimic states in catalytic cycle of cytochrome P-450 and peroxidases

N. Daéid, K. Nolan, S. Atkinson, 1993 .

Spectroscopic models for cytochrome P-450 derivatives: hyperporphyrin spectra in thiolatoiron(III)–porphyrin complexes

K. Nolan, 1986 .

Copper(II) complexes of hydrolysis products of the anticancer bis(3,5-dioxopiperazin-1-yl)alkanes. Displacement of co-ordinated carboxylate ligands by deprotonated amide groups in basic solution

N. Daéid, K. Nolan, L. P. Ryan, 1991 .

Chelating agents as antitumour drugs: Formation of chelating agents from the antitumour pro-drug, razoxane

A. Creighton, T. Murphy, K. Nolan, 1990 .

Metal complexes of the angiotensin-converting enzyme inhibitor, lisinopril. Solution studies and the crystal and molecular structure of a dimeric copper( II )–lisinopril complex

K. Nolan, A. Yanovsky, E. Farkas, 1997 .